Physician profile
Troy Martin
NPI 1710907761
$4,312.73
in general payments reported to CMS, 2019-2025
16 companies · $713 in 2025
The $713 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $463 · 2021: $725 · 2022: $719 · 2023: $681 · 2024: $524 · 2025: $713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,904 · Entertainment: $13.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,904.18 |
| Entertainment | $13.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,040.15 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,047.31 | 2019-2025 | |
| Pfizer INC. | $476.74 | 2019-2021 | |
| Axsome Therapeutics, INC. | $223.22 | 2025 | Auvelity |
| Abbott Laboratories | $133.28 | 2023 | Diamondback Coronary |
| Idorsia Pharmaceuticals US INC | $95.05 | 2022 | |
| Lilly USA, LLC | $76.35 | 2019-2025 | Mounjaro, Zepbound |
| Allergan, INC. | $47.96 | 2020 | |
| Neos Therapeutics, LP | $33.86 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $29.49 | 2024-2025 | Breztri, Airsupra |
| Amgen INC. | $27.22 | 2022-2024 | Otezla, Repatha |
| Sanofi Pasteur INC. | $22.64 | 2019-2021 | |
| Ethicon US, LLC | $20.03 | 2019 | |
| Astellas Pharma US INC | $13.90 | 2023 | Veozah |
| Optos, INC. | $13.84 | 2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.